Sublingual specific immunotherapy.
Mösges
Ralph
R
Institute of Medical Statistics, Informatics and Epidemiology, Cologne University Hospital, Cologne 50931, Germany. ralph@mosges.com
El Hassan
Eelaf
E
Passàli
Desiderio
D
D000286:Administration, Sublingual; D000328:Adult; D000485:Allergens / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D000818:Animals; D018926:Anti-Allergic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology / Q000628:therapy*; D007167:Immunotherapy / Q000379:methods* / Q000639:trends*; D010342:Patient Acceptance of Health Care; D016896:Treatment Outcome
D000485:Allergens; D018926:Anti-Allergic Agents